GTX Corp becomes Authorized Sales Partner of Opu Labs and begins Selling Early Screening COVID Test
GTX Corp (OTC: GTXO) announced the launch of sales for a new asymptomatic COVID screening test with 96.8% accuracy. This non-invasive test, which can be self-administered using a simple smell test and an app, provides immediate results in less than a minute. It aims to provide an affordable pre-screening solution for individuals and organizations, allowing early detection of COVID-19. Opu Labs CEO emphasizes the test's ability to detect the virus early through the olfactory glands.
- Launched asymptomatic COVID screening tests with 96.8% accuracy.
- Non-invasive and self-administered, providing immediate results.
- Affordable pre-screening solution for home, office, or school use.
- None.
LOS ANGELES, CALIFORNIA, Dec. 29, 2021 (GLOBE NEWSWIRE) -- GTX Corp (OTC: GTXO) (“GTX” or the “Company”), a pioneer in the field of health and safety wearable GPS human and asset tracking systems and a supplier of personal protective medical equipment, announced today that it has begun sales and distribution of asymptomatic COVID screening tests.
This simple, noninvasive screening test provides results immediately with
- Asymptomatic screening at PCR levels.
96.8% Accurate.- Non-invasive – safer and much less painful than standard nasal swab.
- Easy self-administered through a simple smell test and app, no waiting in long lines.
- No medical staff needed to administer.
- Takes less than 1 minute with immediate results.
- Digital time stamped record of the test for proof and validation.
- Digital Real-time, authenticated passes which can be stored on your phone and verified at all building and room entry points.
“GTX’s experience and success marketing PPE including antibody and antigen test kits, makes them a perfect partner for us to address the urgent need for early screening. To date
“We are very excited to introduce this innovative, affordable, quick, safe, and easy prescreening digital smell test. It is the ultimate early detection solution to usher in the new normal way of life with COVID-19. Peace of mind never smelled so good,” stated Patrick Bertagna, GTX Corp CEO.
Widely known for its patented GPS SmartSole and Smartphone GPS Tracking App, GTX also distributes an extensive line of Personal Protective Equipment “PPE”, owns and licenses a large portfolio of patents in the GPS and wearable technology space, and is a GSA-approved military and government supplier. Many of the Company’s products are available at its online store and Amazon. To find out more about how you can buy or become an authorized reseller of GTX products, contact our info@gtxcorp.com business development office.
About Opu Labs, Inc. Opu Labs markets and develops AI and blockchain based health and wellness applications. The company’s services help consumers analyze their health as well as manage, monitor, and monetize their health data. Opu AI technology analyzes images of the face and skin to assess health conditions, aging, as well as the risk of viral infections including COVID-19. In addition, Opu Labs is an authorized global direct partner for Corowell’s olfactory (smell) test. With the benefits of security, privacy, and control, the Opu Platform provides a transparent and efficient data marketplace for decentralized healthcare information. Opu Labs is set out to improve how the global healthcare industry exchanges data, information, and rewards in a way that benefits patients, doctors, manufacturers, and service providers.
About GTX Corp GTX Corp (OTC: GTXO) is a pioneer in smart, mobile, and wearable GPS tracking and recovery location-based solutions, supported through a proprietary IoT enterprise monitoring platform and intellectual property portfolio. GTX offers a global end-to-end solution of hardware, software and connectivity and develops two-way GPS tracking technologies, which seamlessly integrate with consumer products and enterprise applications. GTX utilizes the latest in miniaturized, low power consumption GPS, Cellular, RF, NFC and BLE technology, enabling subscribers to track in real time the whereabouts of people or high value assets. GTX is known for its game-changing and award-winning patented GPS SmartSole® -- think Dr. Scholl’s meets LoJack, the world’s first invisible wearable technology tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism and traumatic brain injury. GTX’s business model is built around technology innovation and holds over 85 patents, with many issued patents in GPS tracking. The company has international distributors servicing customers in over 35 countries and is a U.S. Military Government contractor. Other customers include public health authorities and municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes, and consumers.
GTXCorp.com Track My Workforce GPS SmartSole.com
Social Media Hashtags - #withyou #smartsole #connectedandprotected #trackwhatyoulove
#iot #smartproducts #nfc #ble #safety #healthcare #veritap #exceptionmonitoring #assettracking #coronavirus #face mask #covid19
GTX Blog https://gtxcorp.com/press/
https://www.facebook.com/gtxcorpcom
https://www.twitter.com/gtxc
https://www.linkedin.com/in/gtxcorp
https://www.pinterest.com/GTXCorp/
https://instagram.com/gtxcorp
General information, investor relations, wholesale licensing, consumer purchase:
213.489.3019
Info@GTXCorp.com
IR@GTXCorp.com
Contact Us
GTX Corp United Kingdom
In the UK, GTX Corp operates from its London office. Please contact: Nelson Skip Riddle
Email: NSRiddle@GTXCorp.com Tel: +44 7785 364100
Disclaimer: GTX Corp does not warrant or represent that the unauthorized use of materials drawn from the content of this document will not infringe rights of third parties who are not owned or affiliated by GTX Corp. Further GTX Corp cannot be held responsible or liable for the unauthorized use of this document’s content by third parties unknown to the company.
Forward Looking Statements
This news release contains forward-looking statements. The terms and phrases “expect,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by GTX considering its experience and its perception of current conditions and expected future developments, as well as other factors that GTX believes are appropriate in the circumstances. Many factors could cause GTX’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are set forth in GTX’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not place undue reliance on GTX’s forward-looking statements. GTX has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
FAQ
What is the new product launched by GTX Corp?
How quickly do the new COVID screening tests provide results?
What is the accuracy rate of GTX Corp's COVID screening test?
What are the benefits of GTX Corp's new COVID screening test?
Who is the CEO of GTX Corp?
What is the stock symbol for GTX Corp?
